Kapoor et al. identified changes in the urinary levels of organic acids and organic compounds in patients with RA and PsA before and after treatment with the anti-tumor necrosis factor α (anti-TNFα) agents infliximab and etanercept [41]. The gene discussed is TNF; the disease is rheumatoid arthritis.